Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -183.45% is in line with its 5-year average of -171.80%, around the middle of its 5-year range (-379.78%–-49.83%).
As of the fiscal period ended Tuesday, June 30, 2026. 79.70% below its 12-month average of -102.09%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): -183.45%.
RETURN ON INVESTED CAPITAL (ROIC)
-183.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-102.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-210.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-171.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-167.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-206.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-79.70%
CURRENT VS 3Y AVG
+12.77%
CURRENT VS 5Y AVG
-6.78%
CURRENT VS 10Y AVG
-9.35%
CURRENT VS 15Y AVG
+11.24%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-414.45%
vs the sector median at left
NeuroOne Medical Technologies Corporation
Market Cap
$9.83M
Return on Invested Capital (ROIC)
-183.45%
TTM Avg
-102.09%
3Y Avg
-210.32%
5Y Avg
-171.80%
Market Cap
$9.86M
Return on Invested Capital (ROIC)
-55.13%
TTM Avg
-99.85%
3Y Avg
-167.97%
5Y Avg
-308.25%
Market Cap
$9.75M
Return on Invested Capital (ROIC)
-215.61%
TTM Avg
-191.09%
3Y Avg
-141.72%
5Y Avg
-179.96%
Market Cap
$9.71M
Return on Invested Capital (ROIC)
-59.35%
TTM Avg
-68.11%
3Y Avg
-104.39%
5Y Avg
-133.77%
Market Cap
$10.06M
Return on Invested Capital (ROIC)
-269.16%
TTM Avg
-387.93%
3Y Avg
-400.47%
5Y Avg
-400.47%
Market Cap
$10.06M
Return on Invested Capital (ROIC)
-227.67%
TTM Avg
-121.58%
3Y Avg
-92.03%
5Y Avg
-78.85%
Market Cap
$10.13M
Return on Invested Capital (ROIC)
-323.71%
TTM Avg
-133.57%
3Y Avg
-246.04%
5Y Avg
-170.10%
Market Cap
$9.50M
Return on Invested Capital (ROIC)
-80.51%
TTM Avg
-60.18%
3Y Avg
-50.63%
5Y Avg
-247.68%
Market Cap
$10.21M
Return on Invested Capital (ROIC)
-95.42%
TTM Avg
-108.10%
3Y Avg
-72.41%
5Y Avg
-59.15%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroOne Medical Technologies Corporation (NMTC) | $9.83M | -183.45% | -102.09% | -210.32% | -171.80% |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | -55.13% | -99.85% | -167.97% | -308.25% |
| MetaVia Inc. (MTVA)vs › | $9.75M | -215.61% | -191.09% | -141.72% | -179.96% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | -59.35% | -68.11% | -104.39% | -133.77% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -269.16% | -387.93% | -400.47% | -400.47% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | -227.67% | -121.58% | -92.03% | -78.85% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.13M | -323.71% | -133.57% | -246.04% | -170.10% |
| Ainos, Inc. (AIMD)vs › | $9.50M | -80.51% | -60.18% | -50.63% | -247.68% |
| Lifeward Ltd. (LFWD)vs › | $10.21M | -95.42% | -108.10% | -72.41% | -59.15% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | -240.64% | -174.03% | -198.05% | -242.53% |
ROIC
-183.5%
ROE
-189.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -183.45% |
| 2026-03-31 | -112.33% |
| 2025-12-31 | -104.45% |
| 2025-09-30 | -49.83% |
| 2025-06-30 | -60.38% |
| 2025-03-31 | -244.28% |
| 2024-12-31 | -137.82% |
| 2024-09-30 | -376.57% |
| 2024-06-30 | -379.78% |
| 2024-03-31 | -336.02% |
| 2023-12-31 | -305.50% |
| 2023-09-30 | -189.62% |
| 2023-06-30 | -254.12% |
| 2023-03-31 | -166.97% |
| 2022-12-31 | -108.17% |
| 2022-09-30 | -103.16% |
| 2022-06-30 | -104.82% |
| 2022-03-31 | -86.97% |
| 2021-12-31 | -67.51% |
| 2021-09-30 | -151.23% |
| 2021-06-30 | -84.88% |
| 2021-03-31 | -55.97% |
| 2020-12-31 | -302.33% |
| 2020-09-30 | -143.72% |
| 2020-06-30 | -194.65% |
| 2019-12-31 | -745.93% |
| 2019-03-31 | -726.13% |
| 2016-12-31 | -57.22% |
| 2013-03-31 | -329.06% |
| 2012-09-30 | -14890.43% |
| 2012-06-30 | -570.84% |
| 2012-03-31 | -367.67% |
| 2011-12-31 | -297.39% |
| 2011-09-30 | -326.22% |
| 2011-06-30 | -360.93% |
